Jaimiess Kit
Product Images NDC 63629-2345

7 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Jaimiess (NDC 63629-2345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Jaimiess-blistercard (Jaimiess Blister)

Jaimiess-blistercard (Jaimiess Blister)
JAIMIESS extended-cycle tablet dispenser kit containing 91 tablets of levonorgestrel and ethinyl estradiol tablets, USP and ethinyl estradiol tablets, USP. The label shows a 13-week calendar with daily dosing circles arranged by week and day for oral administration. Strengths listed include 0.15 mg levonorgestrel/0.03 mg ethinyl estradiol and 0.01 mg ethinyl estradiol. The labeler is Bryant Ranch Prepack and the package features a barcode and Rx only designation.*
FDA Label Image

Figure 1 (Jaimiess Barchart)

Figure 1 (Jaimiess Barchart)
A bar chart showing the percentage of participants experiencing bleeding and/or spotting versus bleeding alone across four cycles of a study. The x-axis labels four cycles with specific day ranges and sample sizes, while the y-axis shows percentage up to 80%. Each cycle bar segments bleeding alone (striped) and bleeding and/or spotting (white) with percentages noted.*
FDA Label Image

Image Description (Jaimiess Effect Estimate)

Image Description (Jaimiess Effect Estimate)
A forest plot showing comparative effect estimates from several studies on combined oral contraceptive (COC) use versus never use. The horizontal axis represents the effect estimate, with point estimates and confidence intervals plotted for studies such as the NICHD Women's Care Study, French E3N cohort, Shanghai Women's Health Study, and others. Odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals are displayed beside each study name.*
FDA Label Image

Image Description (Jaimiess Ethinyl Estradiol)

Image Description (Jaimiess Ethinyl Estradiol)
Chemical structure diagram of the active ingredients levonorgestrel and ethinyl estradiol, as displayed in the product JAIMIESS kit by Bryant Ranch Prepack.*
FDA Label Image

Image Description (Jaimiess Levonorgestrel)

Image Description (Jaimiess Levonorgestrel)
Chemical structure of the active ingredient levonorgestrel, showing the steroid backbone with specific functional groups including hydroxyl and alkyne substitutions.*
FDA Label Image

Image Description (Jaimiess Flowchart)

Image Description (Jaimiess Flowchart)
A diagram illustrating pregnancy rates per 100 women in one year in relation to different contraceptive methods. It ranks methods by effectiveness from fewer pregnancies (implants, injections, intrauterine devices, sterilization) to more pregnancies (no birth control), including birth control pills, skin patches, vaginal rings, condoms, diaphragm, behavioral methods like no sex during fertile days, spermicide, and withdrawal.*
FDA Label Image

Label (Lbl636292345)

Label (Lbl636292345)
Label for JAIMIESS kit containing levonorgestrel and ethinyl estradiol tablets. It specifies a 13-week supply of 91 tablets in blister packaging, with strengths of 0.15 mg levonorgestrel, 0.03 mg ethinyl estradiol, and 0.01 mg ethinyl estradiol. Labeler is Bryant Ranch Prepack, with manufacturing by Leon Farma S.A. in Spain. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.